有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(4-Ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-1-(5-phenyl-3,4-dihydropyrazol-2-yl)ethanone | —— | C19H24N6O2S |
|
—— | methyl 5-[(2R)-2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]propanoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C19H27N5O4S |
|
—— | 2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R)-1-(4-ethylphenyl)ethyl]acetamide | —— | C20H29N5O2S |
|
—— | N-(1-cyanocyclohexyl)-2-{[4-ethyl-5-(morpholin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide | —— | C17H26N6O2S |
|
—— | 1-(2,5-Dimethyl-1-propan-2-ylpyrrol-3-yl)-2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]ethanone | —— | C19H29N5O2S |
|
—— | 2-[(4-ethyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[[(1R,2S)-2-methylcyclohexyl]carbamoyl]acetamide | —— | C18H30N6O3S |
|
—— | 1-[(6R)-6-hydroxy-1,4-oxazepan-4-yl]-2-pyridin-4-ylsulfanylethanone | —— | C12H16N2O3S |
|
—— | 3-phenyl-N-(sulfanylidenemethylidene)propane-1-sulfonamide | —— | C10H11NO2S2 |
|
—— | 1-[(6S)-6-hydroxy-1,4-oxazepan-4-yl]-2-pyridin-4-ylsulfanylethanone | —— | C12H16N2O3S |
|
—— | N-[2-(furan-2-ylmethyl)pyrazol-3-yl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C20H16N4O2S |
|
—— | cyanomethyl N,N'-diethylcarbamimidothioate | —— | C7H13N3S |
|
—— | [2-(4-acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-2-oxoethyl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C18H21N3O4S |
|
—— | [2-(Cyclohexylamino)-2-oxoethyl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C16H23N3O3S |
|
—— | [2-[2-(4-Chlorophenyl)ethylamino]-2-oxoethyl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C18H20ClN3O3S |
|
—— | [2-(1-Benzyl-2,5-dimethylpyrrol-3-yl)-2-oxoethyl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C23H25N3O3S |
|
—— | [2-(Ethoxycarbonylamino)-2-oxoethyl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C13H17N3O5S |
|
—— | methyl (2S)-2-hydroxy-2-(4-propan-2-ylsulfanylphenyl)acetate | —— | C12H16O3S |
|
—— | 2-(2-ethylsulfanyl-1,3-thiazol-4-yl)-1-[(6R)-6-(hydroxymethyl)-1,4-oxazepan-4-yl]ethanone | —— | C13H20N2O3S2 |
|
—— | 2-(2-ethylsulfanyl-1,3-thiazol-4-yl)-1-[(6S)-6-(hydroxymethyl)-1,4-oxazepan-4-yl]ethanone | —— | C13H20N2O3S2 |
|
—— | 1-[(3R)-3,5-dithiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-methyltetrazol-5-yl)sulfanylethanone | —— | C15H14N6OS3 |
|
—— | 3-[5-[2-[2-Cyanoethyl(methyl)amino]-2-oxoethyl]sulfanyl-4-methyl-1,2,4-triazol-3-yl]propanamide | —— | C12H18N6O2S |
|
—— | methyl (2R)-2-hydroxy-2-(4-propan-2-ylsulfanylphenyl)acetate | —— | C12H16O3S |
|
—— | (6S)-4-(2-methylsulfanylpyrimidin-4-yl)-6-(pyrrolidin-1-ylmethyl)-1,4-oxazepan-6-ol | —— | C15H24N4O2S |
|
—— | (2R)-1-methoxy-2-(4-propan-2-ylsulfanylphenyl)propan-2-amine | —— | C13H21NOS |
|
—— | (6R)-4-(2-methylsulfanylpyrimidin-4-yl)-6-(pyrrolidin-1-ylmethyl)-1,4-oxazepan-6-ol | —— | C15H24N4O2S |
|
—— | (2S)-1-methoxy-2-(4-propan-2-ylsulfanylphenyl)propan-2-amine | —— | C13H21NOS |
|
—— | 3-(4-ethylsulfanyl-N-methylanilino)propanoic acid | —— | C12H17NO2S |
|
—— | 2-(1-methyl-1<i>H</i>-tetrazol-5-ylsulfanyl)-3-nitro-pyridine | 59888-16-3 | C7H6N6O2S |
|
—— | 1-[1-[(4-Fluorophenyl)methyl]-2,5-dimethylpyrrol-3-yl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]ethanone | —— | C21H23FN4OS |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(3S)-1,1-dioxothiolan-3-yl]-N-(2-methylpropyl)acetamide | —— | C14H23N5O3S2 |
|
—— | ethyl 2-[2-[(1S)-1-cyanoethyl]sulfanyl-1,3-thiazol-4-yl]acetate | —— | C10H12N2O2S2 |
|
—— | 1-[(Z)-[(1R)-cyclohex-3-en-1-yl]methylideneamino]-3-[4-(difluoromethylsulfanyl)phenyl]thiourea | —— | C15H17F2N3S2 |
|
—— | ethyl 2-[2-[(1R)-1-cyanoethyl]sulfanyl-1,3-thiazol-4-yl]acetate | —— | C10H12N2O2S2 |
|
—— | N-[(4-fluorophenyl)methyl]-N-methyl-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C14H15FN2OS2 |
|
—— | (2S)-3-(4-methylphenyl)-2-(1-methyltetrazol-5-yl)sulfanylpropanenitrile | —— | C12H13N5S |
|
—— | 6-Amino-3-methyl-1-(2-methylpropyl)-5-(2-pyrimidin-2-ylsulfanylacetyl)pyrimidine-2,4-dione | —— | C15H19N5O3S |
|
—— | (3R)-3-[2-(2-propylsulfanylpyrimidin-5-yl)imidazol-1-yl]piperidin-2-one | —— | C15H19N5OS |
|
—— | (2R)-3-(4-methylphenyl)-2-(1-methyltetrazol-5-yl)sulfanylpropanenitrile | —— | C12H13N5S |
|
—— | 2-(Pyrimidin-2-ylthio)-1-(1h-pyrrol-2-yl)ethan-1-one | —— | C10H9N3OS |
|
—— | 3-(3-Methyl-2,4-dioxo-7-propan-2-yl-1-propylpyrimido[4,5-d]pyrimidin-5-yl)sulfanylpropanenitrile | —— | C16H21N5O2S |
|
—— | N-(2-fluorophenyl)-5-thieno[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazol-2-amine | —— | C14H8FN5S3 |
|
—— | (5S)-5-[2-[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]imidazol-1-yl]-4,5,6,7-tetrahydro-1H-indazole | —— | C17H17N7OS |
|
—— | (5R)-5-[2-[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]imidazol-1-yl]-4,5,6,7-tetrahydro-1H-indazole | —— | C17H17N7OS |
|
—— | (2S)-3-methyl-1-(2,4,6-trimethylphenyl)sulfanylbutan-2-amine | —— | C14H23NS |
|
—— | (3R)-1-[(2-propylsulfanylpyrimidin-5-yl)methyl]-3-(pyrrolidin-1-ylmethyl)piperidin-3-ol | —— | C18H30N4OS |
|
—— | (3S)-1-[(2-propylsulfanylpyrimidin-5-yl)methyl]-3-(pyrrolidin-1-ylmethyl)piperidin-3-ol | —— | C18H30N4OS |
|
—— | (2R)-3-methyl-1-(2,4,6-trimethylphenyl)sulfanylbutan-2-amine | —— | C14H23NS |
|
—— | 2-[(5-Anilino-1,3,4-thiadiazol-2-yl)sulfanyl]-1-(4-methylpiperazin-1-yl)ethanone | —— | C15H19N5OS2 |
|
—— | 4-(4-ethylsulfanylphenyl)-N,2-dimethylbutan-2-amine | —— | C14H23NS |
|
—— | 4-[(4,5-Dimethyl-1,2,4-triazol-3-yl)sulfanyl]-6-phenylthieno[2,3-d]pyrimidine | —— | C16H13N5S2 |
|